Medilink Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -45.47%
(FY 2023)
- Profit -158.33%
(FY 2023)
- Ebitda -73.57%
(FY 2023)
- Net Worth -4.55%
(FY 2023)
- Total Assets -1.23%
(FY 2023)
About Medilink Hospital And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Agarwal, Shilpa Agarwal, Riya Agarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110GJ2010PTC060644
- Company No.
060644
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medilink Hospital And Research Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Agarwal  | Director | 11-May-2010 | Current |
| Shilpa Agarwal | Director | 11-May-2010 | Current |
| Riya Agarwal | Director | 18-Aug-2020 | Current |
| Priyansh Agarwal | Director | 12-Dec-2022 | Current |
Financial Performance of Medilink Hospital And Research Centre.
Medilink Hospital And Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 45.47% decrease. The company also saw a substantial fall in profitability, with a 158.33% decrease in profit. The company's net worth dipped by a decrease of 4.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilink Hospital And Research Centre?
In 2023, Medilink Hospital And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medilink Education FoundationActive 8 years 4 monthsManish Agarwal and Shilpa Agarwal are mutual person
- Unigold Pharmachem Private LimitedActive 1 year 7 months
Shilpa Agarwal and Priyansh Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medilink Hospital And Research Centre?
Medilink Hospital And Research Centre has a workforce of 2 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilink Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilink Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
